CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($) $ in Millions |
6 Months Ended |
Apr. 30, 2017 |
Apr. 30, 2016 |
| Cash flows from operating activities: |
|
|
| Net Income |
$ 158
|
$ 152
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
| Depreciation and amortization |
73
|
67
|
| Share-based compensation |
31
|
29
|
| Excess tax benefit from share-based plans |
(2)
|
0
|
| Debt issuance expense |
9
|
0
|
| Deferred taxes |
(13)
|
3
|
| Excess and obsolete inventory related charges |
6
|
11
|
| Gain on sale of land |
(8)
|
(10)
|
| Asset impairment |
7
|
0
|
| Other non-cash expenses, net |
1
|
2
|
| Changes in assets and liabilities: |
|
|
| Accounts receivable |
10
|
(3)
|
| Inventory |
(10)
|
(11)
|
| Accounts payable |
(17)
|
(27)
|
| Employee compensation and benefits |
0
|
11
|
| Retirement and post-retirement benefits, net |
(74)
|
(25)
|
| Income tax payable |
(7)
|
2
|
| Other assets and liabilities |
(13)
|
8
|
| Net cash provided by operating activities |
151
|
209
|
| Cash flows from investing activities: |
|
|
| Investments in property, plant and equipment |
(33)
|
(62)
|
| Proceeds from sale of land |
8
|
10
|
| Change in restricted cash and cash equivalents, net |
1
|
0
|
| Proceeds from sale of investments |
4
|
0
|
| Acquisition of businesses and intangible assets, net of cash acquired |
(1,622)
|
(10)
|
| Net cash used in investing activities |
(1,642)
|
(62)
|
| Cash flows from financing activities: |
|
|
| Proceeds from issuance of common stock under employee stock plans |
21
|
24
|
| Proceeds from issuance of common stock under public offering |
444
|
0
|
| Excess tax benefit from share-based plans |
2
|
0
|
| Proceeds from short-term borrowings |
170
|
0
|
| Proceeds from issuance of long-term debt |
1,069
|
0
|
| Payment of debt issuance costs |
(16)
|
0
|
| Treasury stock repurchases |
0
|
(40)
|
| Net Cash provided by (used in) financing activities |
1,690
|
(16)
|
| Effect of exchange rate movements |
1
|
6
|
| Net increase in cash and cash equivalents |
200
|
137
|
| Cash and cash equivalents at beginning of period |
783
|
483
|
| Cash and cash equivalents at end of period |
$ 983
|
$ 620
|